Glenmark Pharmaceuticals to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) single-dose…
Glenmark Pharmaceuticals, a research‐led, global pharmaceutical company has announced the launch of Eribulin Mesylate Injection, 1…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.